Global Opthalmic Therapeutics Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Buy Now

   Published Date : Dec-2017   |    Format : PDF   |    Pages : 107
This report studies the global Opthalmic Therapeutics market, analyzes and researches the Opthalmic Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Pfizer
    Novartis
    GlaxoSmithKline
    Alcon
    Merck
    F. Hoffmann-La Roche
    Bayer
    Actavis
    Boehringer Ingelheim
    R-Tech Ueno
    Valeant Pharmaceuticals
    Regeneron Pharmaceuticals
    Acadia Pharmaceuticals
    Allergan
    Falcon Pharmaceuticals
    Otsuka Pharmaceutical
    Senju Pharmaceutical
    OPKO Health
    Lexicon Pharmaceuticals

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Oral
    Injection
    External Application

Market segment by Application, Opthalmic Therapeutics can be split into
    Hospitals
    Clinics
    Home Care Settings
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Opthalmic Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Opthalmic Therapeutics
    1.1  Opthalmic Therapeutics Market Overview
        1.1.1 Opthalmic Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Opthalmic Therapeutics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Opthalmic Therapeutics Market by Type
        1.3.1 Oral
        1.3.2 Injection
        1.3.3 External Application
    1.4 Opthalmic Therapeutics Market by End Users/Application
        1.4.1 Hospitals
        1.4.2 Clinics
        1.4.3 Home Care Settings
        1.4.4 Other

2 Global Opthalmic Therapeutics Competition Analysis by Players
    2.1 Opthalmic Therapeutics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Pfizer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 GlaxoSmithKline
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Alcon
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Merck
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 F. Hoffmann-La Roche
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Bayer
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Actavis
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Boehringer Ingelheim
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 R-Tech Ueno
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Valeant Pharmaceuticals
    3.12 Regeneron Pharmaceuticals
    3.13 Acadia Pharmaceuticals
    3.14 Allergan
    3.15 Falcon Pharmaceuticals
    3.16 Otsuka Pharmaceutical
    3.17 Senju Pharmaceutical
    3.18 OPKO Health
    3.19 Lexicon Pharmaceuticals

4 Global Opthalmic Therapeutics Market Size by Type and Application (2012-2017)
    4.1 Global Opthalmic Therapeutics Market Size by Type (2012-2017)
    4.2 Global Opthalmic Therapeutics Market Size by Application (2012-2017)
    4.3 Potential Application of Opthalmic Therapeutics in Future
    4.4 Top Consumer/End Users of Opthalmic Therapeutics

5 United States Opthalmic Therapeutics Development Status and Outlook
    5.1 United States Opthalmic Therapeutics Market Size (2012-2017)
    5.2 United States Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Opthalmic Therapeutics Development Status and Outlook
    6.1 EU Opthalmic Therapeutics Market Size (2012-2017)
    6.2 EU Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Opthalmic Therapeutics Development Status and Outlook
    7.1 Japan Opthalmic Therapeutics Market Size (2012-2017)
    7.2 Japan Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Opthalmic Therapeutics Development Status and Outlook
    8.1 China Opthalmic Therapeutics Market Size (2012-2017)
    8.2 China Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Opthalmic Therapeutics Development Status and Outlook
    9.1 India Opthalmic Therapeutics Market Size (2012-2017)
    9.2 India Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Opthalmic Therapeutics Development Status and Outlook
    10.1 Southeast Asia Opthalmic Therapeutics Market Size (2012-2017)
    10.2 Southeast Asia Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Opthalmic Therapeutics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.4 China Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.5 India Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
    11.2 Global Opthalmic Therapeutics Market Size (Value) by Type (2017-2022)
    11.3 Global Opthalmic Therapeutics Market Size by Application (2017-2022)

12 Opthalmic Therapeutics Market Dynamics
    12.1 Opthalmic Therapeutics Market Opportunities
    12.2 Opthalmic Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Opthalmic Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Opthalmic Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Opthalmic Therapeutics Product Scope
    Figure Global Opthalmic Therapeutics Market Size (Million USD) (2012-2017)
    Table Global Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Opthalmic Therapeutics Market Share by Regions in 2016
    Figure United States Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Opthalmic Therapeutics Market Share by Type in 2016
    Figure Oral Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Injection Market Size (Million USD) and Growth Rate (2012-2017)
    Figure External Application Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Opthalmic Therapeutics Market Share by Application in 2016
    Table Key Downstream Customer in Hospitals
    Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
    Table Key Downstream Customer in Clinics
    Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
    Table Key Downstream Customer in Home Care Settings
    Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Home Care Settings (2012-2017)
    Table Key Downstream Customer in Other
    Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
    Table Opthalmic Therapeutics Market Size (Million USD) by Players (2016 and 2017)
    Figure Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure Opthalmic Therapeutics Market Size Share by Players in 2017
    Table Pfizer Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
    Figure Pfizer Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table GlaxoSmithKline Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
    Figure GlaxoSmithKline Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Alcon Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Alcon (2012-2017)
    Figure Alcon Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Merck Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
    Figure Merck Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table F. Hoffmann-La Roche Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
    Figure F. Hoffmann-La Roche Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Bayer Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Bayer (2012-2017)
    Figure Bayer Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Actavis Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Actavis (2012-2017)
    Figure Actavis Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Boehringer Ingelheim Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
    Figure Boehringer Ingelheim Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table R-Tech Ueno Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of R-Tech Ueno (2012-2017)
    Figure R-Tech Ueno Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Valeant Pharmaceuticals Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)
    Figure Valeant Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Regeneron Pharmaceuticals Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Regeneron Pharmaceuticals (2012-2017)
    Figure Regeneron Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Acadia Pharmaceuticals Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Acadia Pharmaceuticals (2012-2017)
    Figure Acadia Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Allergan Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Allergan (2012-2017)
    Figure Allergan Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Falcon Pharmaceuticals Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Falcon Pharmaceuticals (2012-2017)
    Figure Falcon Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Otsuka Pharmaceutical Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Otsuka Pharmaceutical (2012-2017)
    Figure Otsuka Pharmaceutical Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Senju Pharmaceutical Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Senju Pharmaceutical (2012-2017)
    Figure Senju Pharmaceutical Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table OPKO Health Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of OPKO Health (2012-2017)
    Figure OPKO Health Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Lexicon Pharmaceuticals Basic Information List
    Table Opthalmic Therapeutics Business Revenue (Million USD) of Lexicon Pharmaceuticals (2012-2017)
    Figure Lexicon Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
    Table Global Opthalmic Therapeutics Market Size (Million USD) by Type (2012-2017)
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2012
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2013
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2014
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2015
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2016
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2017
    Table Global Opthalmic Therapeutics Market Size (Million USD) by Application (2012-2017)
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2012
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2013
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2014
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2015
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2016
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Opthalmic Therapeutics
    Figure United States Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure United States Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure United States Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure EU Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure EU Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure EU Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure Japan Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure Japan Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure Japan Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure China Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure China Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure China Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure India Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure India Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure India Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure Southeast Asia Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Opthalmic Therapeutics Market Size Share by Players in 2016
    Figure Southeast Asia Opthalmic Therapeutics Market Size Share by Players in 2017
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Regions (2017-2022)
    Table Global Opthalmic Therapeutics Market Size (Million USD) by Regions (2017-2022)
    Figure Global Opthalmic Therapeutics Market Size Share by Regions in 2017
    Figure Global Opthalmic Therapeutics Market Size Share by Regions in 2022
    Figure United States Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Opthalmic Therapeutics Market Size (Million USD) by Type (2017-2022)
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2017
    Figure Global Opthalmic Therapeutics Market Size Share by Type in 2022
    Table Global Opthalmic Therapeutics Market Size (Million USD) by Application (2017-2022)
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2017
    Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2022



Latest News

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...

05-Feb-2019 | Electrical & Electronic Device

Big Data—A Powerful Element To Change The Trend Of E-Commerce Market

E-commerce had a record year in 2018, with worldwide revenue estimated at $ 2.8 Trillion, according to statistics. This number is expected to reach $ 3.5 Trillion this year. To put this in perspective; if the e-commerce industry were a country, it would be the fifth; ahead to the UK, whose GDP in April 2018 was $ 2.61 Trillion.

15-Jan-2019 | Medical Devices

Discoveries That Curb Spread Of Antibiotic Resistance To Boost The Growth Of Antibiotics Market

The rising use of antibiotics owing to high prevalence of severe infections, the elevated capital allotment for Research & Development activities by biotechnology firms, along with the supportive rules and standards have propelled the growth of the antibiotics market. Furthermore, the breakthrough of innovative combination therapies and advanced prospect molecules for treating antibiotic-re ...